Anaplastic lymphoma kinase (ALK) is activated predominantly as an EML4-ALK fusion protein, especially in non-small cell lung cancer (NSCLC), and promotes cancer cell proliferation [105]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.